Source:http://linkedlifedata.com/resource/pubmed/id/17018597
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
2006-10-4
|
pubmed:abstractText |
Primary brain tumors are the fourth leading cause of cancer mortality in adults under the age of 54 years and the leading cause of cancer mortality in children in the United States. Therapy for the most common type of primary brain tumors, gliomas, remains suboptimal. The development of new and more effective treatments will likely require a better understanding of the biology of these tumors. Here, we show that use of the high-density 100K single-nucleotide polymorphism arrays in a large number of primary tumor samples allows for a much higher resolution survey of the glioma genome than has been previously reported in any tumor type. We not only confirmed alterations in genomic areas previously reported to be affected in gliomas, but we also refined the location of those sites and uncovered multiple, previously unknown regions that are affected by copy number alterations (amplifications, homozygous and heterozygous deletions) as well as allelic imbalances (loss of heterozygosity/gene conversions). The wealth of genomic data produced may allow for the development of a more rational molecular classification of gliomas and serve as an important starting point in the search for new molecular therapeutic targets.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/EGFR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1538-7445
|
pubmed:author |
pubmed-author:CenterAngelaA,
pubmed-author:ChristopherNeilN,
pubmed-author:FineHoward AHA,
pubmed-author:HeissJohnJ,
pubmed-author:KotliarovYuriY,
pubmed-author:MR GRG,
pubmed-author:MikkelsenTomT,
pubmed-author:RosenblumMarkM,
pubmed-author:SteedMary EllenME,
pubmed-author:WallingJenniferJ,
pubmed-author:ZenklusenJean CJC
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9428-36
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17018597-Alleles,
pubmed-meshheading:17018597-Brain Neoplasms,
pubmed-meshheading:17018597-DNA, Neoplasm,
pubmed-meshheading:17018597-Gene Amplification,
pubmed-meshheading:17018597-Gene Dosage,
pubmed-meshheading:17018597-Genomic Library,
pubmed-meshheading:17018597-Glioma,
pubmed-meshheading:17018597-Humans,
pubmed-meshheading:17018597-Loss of Heterozygosity,
pubmed-meshheading:17018597-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:17018597-Polymerase Chain Reaction,
pubmed-meshheading:17018597-RNA, Messenger,
pubmed-meshheading:17018597-RNA, Neoplasm,
pubmed-meshheading:17018597-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17018597-United States
|
pubmed:year |
2006
|
pubmed:articleTitle |
High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.
|
pubmed:affiliation |
Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD 20892-4254, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|